Free Trial

Jones Financial Companies Lllp Purchases New Stake in Scholar Rock Holding Corporation $SRRK

Scholar Rock logo with Medical background

Key Points

  • Jones Financial Companies Lllp has acquired a new stake in Scholar Rock Holding Corporation, purchasing 36,044 shares valued at approximately $1,159,000 during the first quarter.
  • Insider transactions include Mo Qatanani selling 24,066 shares and Jeffrey S. Flier selling 11,136 shares, leading to significant decreases in their ownership percentages.
  • Analysts have largely rated Scholar Rock positively, with a consensus target price of $45.75, though the company reported earnings that missed estimates, leading to a current stock price of $31.67.
  • Five stocks we like better than Scholar Rock.

Jones Financial Companies Lllp purchased a new stake in Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 36,044 shares of the company's stock, valued at approximately $1,159,000.

Other hedge funds also recently made changes to their positions in the company. CWM LLC raised its stake in shares of Scholar Rock by 152.8% during the first quarter. CWM LLC now owns 996 shares of the company's stock valued at $32,000 after purchasing an additional 602 shares during the period. Federated Hermes Inc. purchased a new stake in shares of Scholar Rock during the first quarter valued at approximately $71,000. GF Fund Management CO. LTD. raised its stake in shares of Scholar Rock by 21.9% during the first quarter. GF Fund Management CO. LTD. now owns 2,396 shares of the company's stock valued at $77,000 after purchasing an additional 430 shares during the period. AlphaQuest LLC raised its stake in shares of Scholar Rock by 490.7% during the first quarter. AlphaQuest LLC now owns 5,417 shares of the company's stock valued at $174,000 after purchasing an additional 4,500 shares during the period. Finally, Tema Etfs LLC purchased a new stake in shares of Scholar Rock during the fourth quarter valued at approximately $209,000. Hedge funds and other institutional investors own 91.08% of the company's stock.

Insider Buying and Selling at Scholar Rock

In other Scholar Rock news, insider Mo Qatanani sold 24,066 shares of the business's stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $34.44, for a total transaction of $828,833.04. Following the completion of the sale, the insider owned 115,495 shares in the company, valued at $3,977,647.80. The trade was a 17.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeffrey S. Flier sold 11,136 shares of the business's stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $40.02, for a total transaction of $445,662.72. Following the sale, the director owned 24,070 shares of the company's stock, valued at approximately $963,281.40. The trade was a 31.63% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 66,654 shares of company stock valued at $2,299,310. 13.30% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SRRK. Raymond James Financial set a $53.00 price objective on shares of Scholar Rock and gave the company a "strong-buy" rating in a research note on Wednesday, July 30th. Cantor Fitzgerald began coverage on shares of Scholar Rock in a research note on Thursday, July 17th. They set an "overweight" rating on the stock. Wedbush reiterated an "outperform" rating and set a $50.00 price objective on shares of Scholar Rock in a research note on Wednesday, June 18th. Jefferies Financial Group assumed coverage on shares of Scholar Rock in a research note on Thursday, August 21st. They issued a "buy" rating and a $50.00 price target for the company. Finally, BMO Capital Markets dropped their price target on shares of Scholar Rock from $57.00 to $45.00 and set an "outperform" rating for the company in a research note on Thursday, August 7th. Two investment analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $45.75.

Read Our Latest Research Report on SRRK

Scholar Rock Stock Down 0.5%

Shares of NASDAQ:SRRK opened at $31.67 on Friday. The company has a current ratio of 6.33, a quick ratio of 6.33 and a debt-to-equity ratio of 0.21. The company has a fifty day simple moving average of $35.11 and a 200 day simple moving average of $33.28. The firm has a market cap of $3.04 billion, a PE ratio of -10.88 and a beta of 0.36. Scholar Rock Holding Corporation has a 12-month low of $6.76 and a 12-month high of $46.98.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.32). During the same quarter in the previous year, the company posted ($0.60) EPS. On average, equities research analysts anticipate that Scholar Rock Holding Corporation will post -2.42 EPS for the current fiscal year.

Scholar Rock Profile

(Free Report)

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.

Recommended Stories

Want to see what other hedge funds are holding SRRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report).

Institutional Ownership by Quarter for Scholar Rock (NASDAQ:SRRK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Scholar Rock Right Now?

Before you consider Scholar Rock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.

While Scholar Rock currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.